HDL quality and functionality: what can proteins and genes predict?

References

• World Health Organization, World Heart Federation and World Stroke Organization. Global Atlas on cardiovascular disease prevention and control. WHO Press; Geneva, Switzerland: 2011
   Google Scholar
• World Health Organization. Global status report on noncommunicable diseases 2010. WHO Press; Geneva, Switzerland: 2011
   Google Scholar
• Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442
   PubMed Web of Science ®Google Scholar
• Rea TD, Pearce RM, Raghunathan TE, et al. Incidence of out-of-hospital cardiac arrest. Am J Cardiol 2004;93:1455-60
   PubMedGoogle Scholar
• Soloff LA. Intermediate lipoproteins, atherosclerosis, and Gofman. Circulation 1998;97:708
   PubMedGoogle Scholar
• Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977;62:707-14
   PubMed Web of Science ®Google Scholar
• Despres JP, Lemieux I, Dagenais GR, et al. HDL-cholesterol as a marker of coronary heart disease risk: the Quebec cardiovascular study. Atherosclerosis 2000;153:263-72
   PubMed Web of Science ®Google Scholar
• Vrecer M, Turk S, Drinovec J, Mrhar A. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials. Int J Clin Pharmacol Ther 2003;41:567-77
   PubMed Web of Science ®Google Scholar
• Neil A, Cooper J, Betteridge J, et al. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J 2008;29:2625-33
   PubMed Web of Science ®Google Scholar
• Sampson UK, Fazio S, Linton MF. Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges. Curr Atheroscler Rep 2012;14:1-10
   PubMed Web of Science ®Google Scholar
• Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8-15
   PubMed Web of Science ®Google Scholar
• Marcel YL, Weech PK, Nguyen TD, et al. Apolipoproteins as the basis for heterogeneity in high-density lipoprotein2 and high-density lipoprotein3. Studies by isoelectric focusing on agarose films. Eur J Biochem 1984;143:467-76
   PubMedGoogle Scholar
• Gofman JW, Glazier F, Tamplin A, et al. Lipoproteins, coronary heart disease, and atherosclerosis. Physiol Rev 1954;34:589-607
   PubMed Web of Science ®Google Scholar
• Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-53
   PubMed Web of Science ®Google Scholar
• Chapman MJ, Assmann G, Fruchart JC, et al. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid–a position paper developed by the European Consensus Panel on HDL-C. Curr Med Res Opin 2004;20:1253-68
   PubMed Web of Science ®Google Scholar
• Badellino KO, Rader DJ. The role of endothelial lipase in high-density lipoprotein metabolism. Curr Opin Cardiol 2004;19:392-5
   PubMedGoogle Scholar
• Nicholls SJ, Gordon A, Johansson J, et al. Efficacy and safety of a novel oral inducer of apolipoprotein A-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial. J Am Coll Cardiol 2011;57:1111-19
   PubMed Web of Science ®Google Scholar
• Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 2003;290:2292-300
   PubMed Web of Science ®Google Scholar
• Sherman CB, Peterson SJ, Frishman WH. Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis. Cardiol Rev 2010;18:141-7
   PubMed Web of Science ®Google Scholar
• Bielicki JK, Zhang H, Cortez Y, et al. A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice. J Lipid Res 2010;51:1496-503
   PubMed Web of Science ®Google Scholar
• Kypreos KE, Gkizas S, Rallidis LS, Karagiannides I. HDL particle functionality as a primary pharmacological target for HDL-based therapies. Biochem Pharmacol 2013;85:1575-8
   PubMedGoogle Scholar
• Boden WE, Probstfield JL, Anderson T, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 2011;365:2255-67
   PubMed Web of Science ®Google Scholar
• Tall AR, Yvan-Charvet L, Wang N. The failure of torcetrapib: was it the molecule or the mechanism? Arterioscler Thromb Vasc Biol 2007;27:257-60
   PubMed Web of Science ®Google Scholar
• Forrest MJ, Bloomfield D, Briscoe RJ, et al. Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone. Br J Pharmacol 2008;154:1465-73
   PubMed Web of Science ®Google Scholar
• Schwartz GG, Olsson AG, Abt M, et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 2012;367:2089-99
   PubMed Web of Science ®Google Scholar
• Barter PJ, Caulfield M, Eriksson M, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007;357:2109-22
   PubMed Web of Science ®Google Scholar
• Soutar AK, Garner CW, Baker HN, et al. Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase. Biochemistry 1975;14:3057-64
   PubMed Web of Science ®Google Scholar
• Chroni A, Liu T, Gorshkova I, et al. The central helices of apoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type apoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo. J Biol Chem 2003;278:6719-30
   PubMedGoogle Scholar
• Fitzgerald ML, Morris AL, Chroni A, et al. ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux. J Lipid Res 2004;45:287-94
   PubMed Web of Science ®Google Scholar
• Kennedy MA, Barrera GC, Nakamura K, et al. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab 2005;1:121-31
   PubMed Web of Science ®Google Scholar
• Gelissen IC, Harris M, Rye KA, et al. ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler Thromb Vasc Biol 2006;26:534-40
   PubMedGoogle Scholar
• Zannis VI, Kardassis D, Zanni EE. Genetic mutations affecting human lipoproteins, their receptors, and their enzymes. Adv Hum Genet 1993;21:145-319
   PubMedGoogle Scholar
• Allan CM, Walker D, Segrest JP, Taylor JM. Identification and characterization of a new human gene (APOC4) in the apolipoprotein E, C-I, and C-II gene locus. Genomics 1995;28:291-300
   PubMed Web of Science ®Google Scholar
• Brewer HB Jr, Fairwell T, LaRue A, et al. The amino acid sequence of human APOA-I, an apolipoprotein isolated from high density lipoproteins. Biochem Biophys Res Commun 1978;80:623-30
   PubMed Web of Science ®Google Scholar
• Nolte RT, Atkinson D. Conformational analysis of apolipoprotein A-I and E-3 based on primary sequence and circular dichroism. Biophys J 1992;63:1221-39
   PubMedGoogle Scholar
• Borhani DW, Rogers DP, Engler JA, Brouillette CG. Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc Natl Acad Sci USA 1997;94:12291-6
   PubMed Web of Science ®Google Scholar
• Timmins JM, Lee JY, Boudyguina E, et al. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J Clin Invest 2005;115:1333-42
   PubMed Web of Science ®Google Scholar
• Brunham LR, Kruit JK, Iqbal J, et al. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J Clin Invest 2006;116:1052-62
   PubMed Web of Science ®Google Scholar
• Liadaki KN, Liu T, Xu S, et al. Binding of high density lipoprotein (HDL) and discoidal reconstituted HDL to the HDL receptor scavenger receptor class B type I. Effect of lipid association and APOA-I mutations on receptor binding. J Biol Chem 2000;275:21262-71
   PubMed Web of Science ®Google Scholar
• Moestrup SK, Kozyraki R. Cubilin, a high-density lipoprotein receptor. Curr Opin Lipidol 2000;11:133-40
   PubMed Web of Science ®Google Scholar
• Smith BT, Mussell JC, Fleming PA, et al. Targeted disruption of cubilin reveals essential developmental roles in the structure and function of endoderm and in somite formation. BMC Dev Biol 2006;6:30
   PubMedGoogle Scholar
• Brewer HB Jr, Lux SE, Ronan R, John KM. Amino acid sequence of human apoLp-Gln-II (apoA-II), an apolipoprotein isolated from the high-density lipoprotein complex. Proc Natl Acad Sci USA 1972;69:1304-8
   PubMed Web of Science ®Google Scholar
• Silva RA, Schneeweis LA, Krishnan SC, et al. The structure of apolipoprotein A-II in discoidal high density lipoproteins. J Biol Chem 2007;282:9713-21
   PubMedGoogle Scholar
• Ko KW, Paul A, Ma K, et al. Endothelial lipase modulates HDL but has no effect on atherosclerosis development in apoE-/- and LDLR-/- mice. J Lipid Res 2005;46:2586-94
   PubMed Web of Science ®Google Scholar
• Chen CH, Albers JJ. Activation of lecithin: cholesterol acyltransferase by apolipoproteins E-2, E-3, and A-IV isolated from human plasma. Biochim Biophys Acta 1985;836:279-85
   PubMed Web of Science ®Google Scholar
• Jackson RL, Sparrow JT, Baker HN, et al. The primary structure of apolopoprotein-serine. J Biol Chem 1974;249:5308-13
   PubMed Web of Science ®Google Scholar
• Jong MC, Gijbels MJ, Dahlmans VE, et al. Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1. J Clin Invest 1998;101:145-52
   PubMedGoogle Scholar
• Jackson RL, Baker HN, Gilliam EB, Gotto AM Jr. Primary structure of very low density apolipoprotein C-II of human plasma. Proc Natl Acad Sci USA 1977;74:1942-5
   PubMed Web of Science ®Google Scholar
• Jong MC, Hofker MH, Havekes LM. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol 1999;19:472-84
   PubMed Web of Science ®Google Scholar
• Brewer HB Jr, Shulman R, Herbert P, et al. The complete amino acid sequence of alanine apolipoprotein (apoC-3), and apolipoprotein from human plasma very low density lipoproteins. J Biol Chem 1974;249:4975-84
   PubMed Web of Science ®Google Scholar
• Kypreos KE. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia. Biochemistry 2008;47:10491-502
   PubMedGoogle Scholar
• Remaley AT, Thomas F, Stonik JA, et al. Synthetic amphipathic helical peptide mediated efflux of lipid from cells by an ABCA1-dependent and an ABCA1-independent pathway. J Lipid Res 2003;44:828-36
   PubMed Web of Science ®Google Scholar
• Rall SC Jr, Weisgraber KH, Innerarity TL, Mahley RW. Identical structural and receptor binding defects in apolipoprotein E2 in hypo-, normo-, and hypercholesterolemic dysbetalipoproteinemia. J Clin Invest 1983;71:1023-31
   PubMed Web of Science ®Google Scholar
• Zannis VI, Kypreos KE, Chroni A, et al. In: Loscalzo J, editor. Molecular mechanisms of atherosclerosis. Taylor & Francis; New York, NY, USA: 2004. p. 111-74
   Google Scholar
• Kowal RC, Herz J, Weisgraber KH, et al. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J Biol Chem 1990;265:10771-9
   PubMed Web of Science ®Google Scholar
• Kypreos KE, Zannis VI. Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT. Biochem J 2007;403:359-67
   PubMedGoogle Scholar
• Gelissen IC, Hochgrebe T, Wilson MR, et al. Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: a potential anti-atherogenic function? Biochem J 1998;331(Pt 1):231-7
   PubMedGoogle Scholar
• Brunzell JD, Deeb SS. In: Scriver CR, Beaudet AL, Valle D, Sly WS, editors. The metabolic & molecular bases of inherited disease. McGraw-Hill; New York, NY, USA: 2001. p. 2789-816
   Google Scholar
• Santamarina-Fojo S, Hoeg JM, Assmann G, Brewer HB Jr. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic & molecular bases of inherited disease. McGraw-Hill; New York, NY, USA: 2001. p. 2817-34
   Google Scholar
• Tall AR, Breslow JL, Rubin EM. In: Scriver CR, Beaudet AL, Valle D, Sly WS, editors. The metabolic & molecular bases of inherited disease. McGraw-Hill; New York, NY, USA: 2001. p. 2915-36
   Google Scholar
• Marais AD. Therapeutic modulation of low-density lipoprotein size. Curr Opin Lipidol 2000;11:597-602
   PubMedGoogle Scholar
• Annema W, Tietge UJ. Role of hepatic lipase and endothelial lipase in high-density lipoprotein-mediated reverse cholesterol transport. Curr Atheroscler Rep 2011;13:257-65
   PubMed Web of Science ®Google Scholar
• Zambon A, Austin MA, Brown BG, et al. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb 1993;13:147-53
   PubMed Web of Science ®Google Scholar
• Jaye M, Lynch KJ, Krawiec J, et al. A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet 1999;21:424-8
   PubMed Web of Science ®Google Scholar
• Hirata K, Dichek HL, Cioffi JA, et al. Cloning of a unique lipase from endothelial cells extends the lipase gene family. J Biol Chem 1999;274:14170-5
   PubMed Web of Science ®Google Scholar
• Rader DJ, Jaye M. Endothelial lipase: a new member of the triglyceride lipase gene family. Curr Opin Lipidol 2000;11:141-7
   PubMedGoogle Scholar
• Ma K, Cilingiroglu M, Otvos JD, et al. Endothelial lipase is a major genetic determinant for high-density lipoprotein concentration, structure, and metabolism. Proc Natl Acad Sci USA 2003;100:2748-53
   PubMed Web of Science ®Google Scholar
• Ishida T, Choi S, Kundu RK, et al. Endothelial lipase is a major determinant of HDL level. J Clin Invest 2003;111:347-55
   PubMed Web of Science ®Google Scholar
• Assmann G, von Eckardstein A, Brewer HB. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disease. McGraw-Hill; New York, NY, USA: 2001. p. 2937-60
   Google Scholar
• Funke H, von Eckardstein A, Pritchard PH, et al. A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity. Proc Natl Acad Sci USA 1991;88:4855-9
   PubMedGoogle Scholar
• Drayna D, Jarnagin AS, McLean J, et al. Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature 1987;327:632-4
   PubMed Web of Science ®Google Scholar
• Chajek T, Fielding CJ. Isolation and characterization of a human serum cholesteryl ester transfer protein. Proc Natl Acad Sci USA 1978;75:3445-9
   PubMed Web of Science ®Google Scholar
• van Tol A. Phospholipid transfer protein. Curr Opin Lipidol 2002;13:135-9
   PubMedGoogle Scholar
• Huuskonen J, Olkkonen VM, Jauhiainen M, Ehnholm C. The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Atherosclerosis 2001;155:269-81
   PubMed Web of Science ®Google Scholar
• Cheung MC, Vaisar T, Han X, et al. Phospholipid transfer protein in human plasma associates with proteins linked to immunity and inflammation. Biochemistry 2010;49:7314-22
   PubMed Web of Science ®Google Scholar
• Oram JF, Wolfbauer G, Tang C, et al. An amphipathic helical region of the N-terminal barrel of phospholipid transfer protein is critical for ABCA1-dependent cholesterol efflux. J Biol Chem 2008;283:11541-9
   PubMedGoogle Scholar
• Tsompanidi EM, Brinkmeier MS, Fotiadou EH, et al. HDL biogenesis and functions: role of HDL quality and quantity in atherosclerosis. Atherosclerosis 2010;208(1):3-9
   PubMedGoogle Scholar
• Bruce C, Chouinard RA Jr, Tall AR. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr 1998;18:297-330
   PubMed Web of Science ®Google Scholar
• Sviridov D, Nestel P. Dynamics of reverse cholesterol transport: protection against atherosclerosis. Atherosclerosis 2002;161:245-54
   PubMed Web of Science ®Google Scholar
• Assmann G, Schulte H, von Eckardstein A, Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996;124(Suppl):S11-20
   PubMed Web of Science ®Google Scholar
• Herscovitz H, Ronen I, Bilu S, Tietz A. Bile acid synthesis from HDL cholesterol and cholesterol ester by cultured chick embryo hepatocytes. Biochim Biophys Acta 1986;878:426-34
   PubMedGoogle Scholar
• Serhan N, Cabou C, Verdier C, et al. Chronic pharmacological activation of P2Y13 receptor in mice decreases HDL-cholesterol level by increasing hepatic HDL uptake and bile acid secretion. Biochim Biophys Acta 2013;1831:719-25
   PubMedGoogle Scholar
• Jolley CD, Dietschy JM, Turley SD. Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein AI. Hepatology 2000;32:1309-16
   PubMedGoogle Scholar
• Makishima M, Okamoto AY, Repa JJ, et al. Identification of a nuclear receptor for bile acids. Science 1999;284:1362-5
   PubMed Web of Science ®Google Scholar
• Parks DJ, Blanchard SG, Bledsoe RK, et al. Bile acids: natural ligands for an orphan nuclear receptor. Science 1999;284:1365-8
   PubMed Web of Science ®Google Scholar
• Wang H, Chen J, Hollister K, et al. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 1999;3:543-53
   PubMed Web of Science ®Google Scholar
• Navab M, Hama SY, Anantharamaiah GM, et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lipid Res 2000;41:1495-508
   PubMed Web of Science ®Google Scholar
• Navab M, Imes SS, Hama SY, et al. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest 1991;88:2039-46
   PubMed Web of Science ®Google Scholar
• Navab M, Hama SY, Cooke CJ, et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lipid Res 2000;41:1481-94
   PubMed Web of Science ®Google Scholar
• Navab M, Reddy S, Van Lenten BJ, et al. Role of dysfunctional HDL in atherosclerosis. J Lipid Res 2008;50:S145-9
   Google Scholar
• Sviridov D, Mukhamedova N, Remaley AT, et al. Antiatherogenic functionality of high density lipoprotein: how much versus how good. J Atheroscler Thromb 2008;15:52-62
   PubMed Web of Science ®Google Scholar
• Barter PJ, Nicholls S, Rye KA, et al. Antiinflammatory properties of HDL. Circ Res 2004;95:764-72
   PubMed Web of Science ®Google Scholar
• Norata GD, Callegari E, Marchesi M, et al. High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells. Circulation 2005;111:2805-11
   PubMed Web of Science ®Google Scholar
• Wadham C, Albanese N, Roberts J, et al. High-density lipoproteins neutralize C-reactive protein proinflammatory activity. Circulation 2004;109:2116-22
   PubMed Web of Science ®Google Scholar
• Jambou D, Dejour N, Bayer P, et al. Effect of human native low-density and high-density lipoproteins on prostaglandin production by mouse macrophage cell line P388D1: possible implications in pathogenesis of atherosclerosis. Biochim Biophys Acta 1993;1168:115-21
   PubMedGoogle Scholar
• Navab M, Berliner JA, Subbanagounder G, et al. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler Thromb Vasc Biol 2001;21:481-8
   PubMed Web of Science ®Google Scholar
• Theilmeier G, De Geest B, Van Veldhoven PP, et al. HDL-associated PAF-AH reduces endothelial adhesiveness in apoE-/- mice. FASEB J 2000;14:2032-9
   PubMed Web of Science ®Google Scholar
• Shah PK, Kaul S, Nilsson J, Cercek B. Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part II. Circulation 2001;104:2498-502
   PubMedGoogle Scholar
• Yin K, Liao DF, Tang CK. ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport. Mol Med 2010;16:438-49
   PubMedGoogle Scholar
• Yvan-Charvet L, Wang N, Tall AR. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol 2010;30:139-43
   PubMed Web of Science ®Google Scholar
• Angeli V, Llodra J, Rong JX, et al. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 2004;21:561-74
   PubMed Web of Science ®Google Scholar
• Gong M, Wilson M, Kelly T, et al. HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner. J Clin Invest 2003;111:1579-87
   PubMed Web of Science ®Google Scholar
• Nofer JR, van der GM, Tolle M, et al. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest 2004;113:569-81
   PubMed Web of Science ®Google Scholar
• Oslakovic C, Krisinger MJ, Andersson A, et al. Anionic phospholipids lose their procoagulant properties when incorporated into high density lipoproteins. J Biol Chem 2009;284:5896-904
   PubMedGoogle Scholar
• Seetharam D, Mineo C, Gormley AK, et al. High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res 2006;98:63-72
   PubMed Web of Science ®Google Scholar
• Tso C, Martinic G, Fan WH, et al. High-density lipoproteins enhance progenitor-mediated endothelium repair in mice. Arterioscler Thromb Vasc Biol 2006;26:1144-9
   PubMed Web of Science ®Google Scholar
• Brooks-Wilson A, Marcil M, Clee SM, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999;22:336-45
   PubMed Web of Science ®Google Scholar
• Karavia EA, Papachristou DJ, Liopeta K, et al. Apolipoprotein A-I modulates processes associated with diet-induced nonalcoholic fatty liver disease in mice. Mol Med 2012;18:901-12
   PubMed Web of Science ®Google Scholar
• Han R, Lai R, Ding Q, et al. Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism. Diabetologia 2007;50:1960-8
   PubMedGoogle Scholar
• Fryirs MA, Barter PJ, Appavoo M, et al. Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion. Arterioscler Thromb Vasc Biol 2010;30:1642-8
   PubMed Web of Science ®Google Scholar
• Fryirs M, Barter PJ, Rye KA. Cholesterol metabolism and pancreatic beta-cell function. Curr Opin Lipidol 2009;20:159-64
   PubMed Web of Science ®Google Scholar
• Kruit JK, Brunham LR, Verchere CB, Hayden MR. HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitus. Curr Opin Lipidol 2010;21:178-85
   PubMed Web of Science ®Google Scholar
• Fan J, Wang J, Bensadoun A, et al. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc Natl Acad Sci USA 1994;91:8724-8
   PubMed Web of Science ®Google Scholar
• Busch SJ, Barnhart RL, Martin GA, et al. Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice. J Biol Chem 1994;269:16376-82
   PubMedGoogle Scholar
• Barbagallo CM, Fan J, Blanche PJ, et al. Overexpression of human hepatic lipase and ApoE in transgenic rabbits attenuates response to dietary cholesterol and alters lipoprotein subclass distributions. Arterioscler Thromb Vasc Biol 1999;19:625-32
   PubMedGoogle Scholar
• Jiang X, Francone OL, Bruce C, et al. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. J Clin Invest 1996;98:2373-80
   PubMedGoogle Scholar
• Jaari S, Van Dijk KW, Olkkonen VM, et al. Dynamic changes in mouse lipoproteins induced by transiently expressed human phospholipid transfer protein (PLTP): importance of PLTP in prebeta-HDL generation. Comp Biochem Physiol B Biochem Mol Biol 2001;128:781-92
   PubMedGoogle Scholar
• Jiang XC, Bruce C, Mar J, et al. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest 1999;103:907-14
   PubMedGoogle Scholar
• Qin S, Kawano K, Bruce C, et al. Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins. J Lipid Res 2000;41:269-76
   PubMed Web of Science ®Google Scholar
• Wang N, Arai T, Ji Y, et al. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice. J Biol Chem 1998;273:32920-6
   PubMed Web of Science ®Google Scholar
• Ji Y, Wang N, Ramakrishnan R, et al. Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile. J Biol Chem 1999;274:33398-402
   PubMed Web of Science ®Google Scholar
• Arai T, Wang N, Bezouevski M, et al. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J Biol Chem 1999;274:2366-71
   PubMed Web of Science ®Google Scholar
• Ueda Y, Gong E, Royer L, et al. Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics. J Biol Chem 2000;275:20368-73
   PubMed Web of Science ®Google Scholar
• Holm TM, Braun A, Trigatti BL, et al. Failure of red blood cell maturation in mice with defects in the high-density lipoprotein receptor SR-BI. Blood 2002;99:1817-24
   PubMed Web of Science ®Google Scholar
• Trigatti B, Rayburn H, Vinals M, et al. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci USA 1999;96:9322-7
   PubMed Web of Science ®Google Scholar
• Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83:356-62
   PubMed Web of Science ®Google Scholar
• Delalla OF, Elliott HA, Gofman JW. Ultracentrifugal studies of high density serum lipoproteins in clinically healthy adults. Am J Physiol 1954;179:333-7
   PubMedGoogle Scholar
• Harman NL, Griffin BA, Davies IG. Separation of the principal HDL subclasses by iodixanol ultracentrifugation. J Lipid Res 2013;54:2273-81
   PubMed Web of Science ®Google Scholar
• Gidez LI, Miller GJ, Burstein M, et al. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 1982;23:1206-23
   PubMed Web of Science ®Google Scholar
• Park YB, Jahani M, Lacko AG. Isolation of high-density lipoproteins by immunoaffinity column chromatography from hog plasma. Comp Biochem Physiol B 1985;82:529-33
   PubMedGoogle Scholar
• Gordon SM, Deng J, Lu LJ, Davidson WS. Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography. J Proteome Res 2010;9:5239-49
   PubMed Web of Science ®Google Scholar
• Asztalos BF, Roheim PS, Milani RL, et al. Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 2000;20:2670-6
   PubMed Web of Science ®Google Scholar
• Alabakovska SB, Todorova BB, Labudovic DD, Tosheska KN. Gradient gel electrophoretic separation of LDL and HDL subclasses on BioRad Mini Protean II and size phenotyping in healthy Macedonians. Clin Chim Acta 2002;317:119-23
   PubMed Web of Science ®Google Scholar
• Gordon SM, Deng J, Tomann AB, et al. Multi-dimensional co-separation analysis reveals protein-protein interactions defining plasma lipoprotein subspecies. Mol Cell Proteomics 2013;12:3123-34
   PubMed Web of Science ®Google Scholar
• Mora S, Otvos JD, Rifai N, et al. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation 2009;119:931-9
   PubMed Web of Science ®Google Scholar
• McQueen MJ, Hawken S, Wang X, et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 2008;372:224-33
   PubMed Web of Science ®Google Scholar
• Kavo AE, Rallidis LS, Sakellaropoulos GC, et al. Qualitative characteristics of HDL in young patients of an acute myocardial infarction. Atherosclerosis 2012;220:257-64
   PubMedGoogle Scholar
• Weissglas-Volkov D, Pajukanta P. Genetic causes of high and low serum HDL-cholesterol. J Lipid Res 2010;51:2032-57
   PubMed Web of Science ®Google Scholar
• Voight BF, Peloso GM, Orho-Melander M, et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012;380:572-80
   PubMed Web of Science ®Google Scholar
• Frikke-Schmidt R, Nordestgaard BG, Stene MC, et al. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA 2008;299:2524-32
   PubMed Web of Science ®Google Scholar
• Roma P, Gregg RE, Meng MS, et al. In vivo metabolism of a mutant form of apolipoprotein A-I, apo A- IMilano, associated with familial hypoalphalipoproteinemia. J Clin Invest 1993;91:1445-52
   PubMed Web of Science ®Google Scholar
• Roberts CK, Ng C, Hama S, et al. Effect of a short-term diet and exercise intervention on inflammatory/anti-inflammatory properties of HDL in overweight/obese men with cardiovascular risk factors. J Appl Physiol 2006;101:1727-32
   PubMed Web of Science ®Google Scholar
• Kontush A, Chapman MJ. Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities. Curr Opin Lipidol 2010;21:312-18
   PubMed Web of Science ®Google Scholar
• Davidson WS, Silva RA, Chantepie S, et al. Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters. relevance to antioxidative function. Arterioscler Thromb Vasc Biol 2009;29(6):870-6
   PubMed Web of Science ®Google Scholar